Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of July 18:

Audentes Therapeutics – San Francisco, 5 million shares, priced $14-$16, manage by BofA/Merrill Lynch/Cowen & Company/Piper Jaffray. Proposed Nasdaq symbol BOLD. Business: Preclinical biotech developing gene therapies for rare diseases.

Gemphire Therapeutics – Northville, Mich., 3.75 million shares, priced $11-$13, managed by Jefferies/RBC Capital Markets. Proposed Nasdaq symbol GEMP. Business: Developing a novel nonstatin therapy to treat high cholesterol.

Impinj – Seattle, 4.6 million shares, priced $12-$14, managed by RBC Capital Markets/Pacific Crest/Piper Jaffray. Business: Leading provider of radio-frequency identification tags and reader chips.

Patheon – Amsterdam, Netherlands, 30.5 million shares, priced $19-$22, managed by J.P. Morgan/Morgan Stanley/Jefferies. Proposed NYSE symbol PTHN. Business: Global provider of contract drug manufacturing and development services.

TPI Composites, Scottsdale, Ariz., 7.25 million shares, priced $15-$17, managed by J.P. Morgan/Morgan Stanley. Proposed Nasdaq symbol TPIC. Business: Largest independent US manufacturer of composite wind blades.

Tactile Systems Technology – Minneapolis, Minn., 4 million shares, priced $14-$16, managed by Piper Jaffray/William Blair/Canaccord Genuity. Proposed Nasdaq symbol TCMD. Business:Sells at-home compression therapy devices for vascular swelling.